Characteristics | Moderate INH, n=1368a | Severe INH, n=212a | OR [95%CI] | p-value | AORb [95%CI] | p-value |
---|---|---|---|---|---|---|
Maternal characteristics | ||||||
 Site, n (%) | ||||||
  Migrant | 464 (33.9) | 60 (28.3) | 1 | 0.107 | – | – |
  Refugee | 904 (66.1) | 152 (71.7) | 1.3 [0.9–1.8] |  | – |  |
 Ethnicity, n (%) | ||||||
  Karen | 1014/1348 (75.2) | 151/198 (76.3) | 1 | 0.434 | – | – |
  Burman | 230/1348 (17.1) | 28/198 (13.2) | 0.8 [0.5–1.2] |  | – | – |
  Other | 104/1348 (7.7) | 19/198 (9.0) | 1.2 [0.7–2.1] |  | – | – |
 Age in years, median, (IQR) | 24 (20–30) | 23 (20–31) | 1.0 [0.9–1.0] | 0.777 | – | – |
 Literacy, n (%) | 846/1280 (66.1) | 101/162 (62.3) | 0.9 [0.6–1.2] | 0.347 | – | – |
 Smoking, n (%) | 189/1364 (13.9) | 33/210 (15.7) | 1.2 [0.8–1.7] | 0.477 | – | – |
 Primigravida, n (%) | 668 (48.8) | 95 (44.8) | 0.9 [0.6–1.1] | 0.276 | – | – |
 Multiple pregnancy, n (%) | 52 (3.8) | 9 (4.2) | 1.1 [0.5–2.3] | 0.758 | – | – |
 Place of birth, n (%) | ||||||
  SMRU | 1241 (90.7) | 182 (85.8) | 1 | 0.011 | – | – |
  Tertiary hospital | 61 (4.5) | 7 (3.3) | 0.8 [0.4–1.7] |  | – | – |
  Home | 58 (4.2) | 19 (9.0) | 2.2 [1.3–3.8] |  | – | – |
  Other | 8 (0.6) | 4 (1.9) | 3.4 [1.0–11.4] |  | – | – |
 Breech and face delivery, n (%) | 36 (2.6) | 13 (6.1) | 2.4 [1.3–4.6] | 0.008 | 2.0 [1.0–4.3] | 0.056 |
 Instrumental vaginal delivery, n (%) | 58 (4.4) | 4 (1.9) | 0.4 [0.2–1.2] | 0.073 | – | – |
Newborn characteristics | ||||||
 Gender (male), n (%) | 796 (58.2) | 126 (59.7) | 1.1 [0.8–1.4] | 0.731 | – | – |
 Small for gestational age, n (%) | 251/1350 (18.6) | 46/204 (15.5) | 1.3 [0.9–1.8] | 0.188 | 1.3 [0.9–2.0] | 0.139 |
 Gestational age, n (%) | ||||||
  < 32 weeks | 38/1367 (2.8) | 15/211 (7.1) | 3.5 [1.9–6.5] | < 0.001 | 3.3 [1.6–6.6] | < 0.001 |
  32 < 37 weeks | 352/1367 (25.7) | 85/211 (40.3) | 2.1 [1.6–2.9] | 2.2 [1.6–3.1] | ||
  ≥ 37 weeks | 977/1367 (71.5) | 111/211 (52.6) | 1 | 1 | ||
 Congenital abnormality, n (%) | 34 (2.5) | 10 (4.7) | 1.9 [1.0–4.0] | 0.089 | 2.4 [1.1–5.3] | 0.027 |
 G6PD deficiency, n (%) | 213/1364 (15.6) | 54 (25.5) | 1.9 [1.3–2.6] | < 0.001 | 2.3 [1.6–3.3] | < 0.001 |
 Potential ABO incompatibility, n (%) | 238/1341 (17.7) | 45/205 (22.0) | 1.3 [0.9–1.9] | 0.155 | 1.5 [1.0–2.2] | 0.032 |
 INH as sole clinical diagnosis, n (%) | 814 (59.5) | 97 (45.8) | 1.7 [1.3–2.3] | < 0.001 | – | – |
 Infection, n (%) | ||||||
  No infection associated | 955 (69.8) | 123 (58.0) | 1 | 0.003 | 1 | 0.006 |
  Associated severe infection | 240 (17.5) | 56 (26.4) | 1.8 [1.3–2.6] |  | 1.8 [1.2–2.7] |  |
  Associated mild infection | 173 (12.6) | 33 (15.6) | 1.5 [0.9–2.3] |  | 1.4 [0.9–2.2] |  |
 Age at presentation, n (%) | ||||||
  0–24 h | 154 (11.3) | 37 (17.5) | 2.1 [1.4–3.3] | < 0.001 | 1.5 [0.9–2.4] | 0.003 |
  > 24–72 h | 160 (55.6) | 85 (40.1) | 1 |  | 1 |  |
  > 72 h | 454 (33.2) | 90 (42.5) | 1.8 [1.3–2.4] |  | 1.8 [1.3–2.6] |  |
 Length of phototherapy in hours, median, (IQR) | 36 (22–66) | 72 (43–133) | – | < 0.001 | – |  |
 Mortality during hospitalization, n, (%) | 14 (1.0) | 17 (8.0) | 8.4 [4.1–17.4] | < 0.001 | – | – |